Clinical Trial Update: Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial evaluating an oral anti-TNF antibody in patients with active ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Oral anti-TNF antibody

Snippet

Sponsor: Avaxia Biologics, Incorporated | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED